SOLV earnings date and last-quarter result: last quarter beat, P/E 9.46. Updated 2026-07-23.
Solventum (SOLV) Research Hub
Solventum (SOLV) trades on NYSE, US in the Healthcare (Medical - Care Facilities) sector. As of 2026-10-26, shares last closed at 85.81 USD (+0.47%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E 9.46, market cap 13.50B. This hub links to the full technical, earnings and options research available for SOLV.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Care Facilities) |
|---|---|
| Exchange | NYSE, US |
| Last close | 85.81 USD (+0.47%) |
| 52-week range | 73.06 USD – 94.16 USD |
| Trend regime | Range |
| 14-day RSI | 45.8 (Neutral) |
| Trailing P/E | 9.46 |
| Market cap | 13.50B |
| Dividend yield | 0.00% |
Available research for SOLV
Covered Call on SOLV: how it works, illustrative setup around the real 85.81 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on SOLV: how it works, illustrative setup around the real 85.81 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on SOLV: how it works, illustrative setup around the real 85.81 USD price, max profit/loss, breakeven and when to use it. Educational.
SOLV technical analysis: range, last 85.81 USD, RSI 45.8, 52w range 73.06 USD–94.16 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is SOLV in?
Solventum (SOLV) is classified under Healthcare (Medical - Care Facilities), listed on NYSE, US.
Is SOLV in an uptrend or downtrend?
As of 2026-10-26, SOLV is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is SOLV's trailing P/E ratio?
SOLV's trailing P/E is 9.46, with a market cap of 13.50B. See the earnings research page for full valuation detail.